Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Governance Other
confidence 75%
filed 2026-06-29
Item 7.01
The company announced its inclusion in the Russell Microcap® Index effective June 29, 2026, which enhances market visibility and is material to institutional investors due to its impact on investment flows and index-tracking fund participation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-29
The filing discloses results of a special meeting of stockholders held on June 24, 2026, where three proposals were voted on and approved: (i) approval of issuance of shares upon exercise of restricted common stock purchase warrants from the February 2026 Private Placement; (ii) approval of issuance of shares upon conversion of Series B Convertible Preferred Stock; and (iii) authorization for the Board to effect a reverse stock split at a ratio between one-for-two and one-for-two hundred fifty. This is a classic Item 5.07 shareholder vote results disclosure with material implications for capital structure and dilution.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-29
Item 8.01
This disclosure announces the completion of a SPAC's IPO, full exercise of the underwriters' over-allotment option (bringing total units to 23 million and gross proceeds to $230 million), and the commencement of separate trading of Class A Ordinary Shares and Warrants on the NYSE. While the IPO itself is a capital-raising event material to investors, it does not fit neatly into the standard taxonomy categories (not earnings_release, debt_issuance, dilutive_issuance, or dividend_distribution). The event is clearly financial and material, but the taxonomy lacks a dedicated SPAC IPO or capital-raising category, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
Quantum Computing Inc. held its Annual Meeting on June 24, 2026, with shareholders voting on five proposals: election of six directors, advisory vote on named executive officer compensation, ratification of independent auditor BPM LLP, approval of a Certificate of Incorporation amendment increasing authorized shares from 260 million to 460 million, and approval of an amendment to the 2022 Equity and Incentive Plan increasing authorized shares from 20 million to 30 million and modifying the evergreen provision.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-06-29
Item 3.03
The Company disclosed a material modification to the rights of security holders, which incorporates amendments to the Certificate of Incorporation and related governance documents affecting voting power, dividend rights, or other fundamental security characteristics.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-29
EX-99.1
The press release announces the closing of a registered direct offering of 3,149,832 ordinary shares at $1.97 per share, generating approximately $6.2 million in gross proceeds. This is a registered equity issuance that dilutes existing shareholders. The offering was conducted pursuant to a shelf registration statement on Form F-3, making it a registered (not unregistered) offering, but it remains a material capital-raising event that increases share count and dilutes ownership. The company explicitly states use of proceeds for general corporate purposes, strategic expansion, and acquisition-related costs.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
Troy W. Ingianni was appointed as Chief Financial Officer, Secretary and Treasurer of TransAct Technologies Inc., effective July 1, 2026, following the retirement of Steven A. DeMartino. Ingianni brings 25+ years of financial leadership experience and was appointed by the Board on June 26, 2026.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-29
EX-99.1
This news release announces exploration drilling results at Collective Mining's Apollo system in Colombia, disclosing the discovery of a new high-grade tungsten-enriched subzone 300 meters below surface with assay results of 27.35m @ 37.55 g/t AuEq (1.68% WO3, 11.62 g/t Au, 54 g/t Ag, 0.43% Cu). The disclosure is a material operational/exploration milestone for an early-stage mining exploration company, demonstrating significant expansion of the Apollo system's scale and depth potential with multiple high-grade intercepts. While not a discrete M&A, financing, or governance event, this exploration success is material to investors' assessment of the company's asset value and development trajectory.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-29
EX-99.1
IsoEnergy discloses a wildfire near its Larocque East project in Saskatchewan that has forced temporary evacuation of field personnel and suspension of exploration activities. While the fire does not currently pose a direct threat to the project site, the Saskatchewan Public Safety Agency has deemed conditions too dangerous for work to proceed. The company expects personnel to remain away for up to one week, though it notes this should not materially impact completion of its 8,000-metre drill program. This is an operational disruption event—a material business interruption caused by external natural phenomena—that does not fit the specific categories of workforce reduction, material litigation, or other named types, but clearly affects the company's near-term operational capacity and project timeline.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-29
EX-99.1
The disclosure announces a reset of the interest rate on $1 billion principal amount of Limited Recourse Capital Notes Series 2021-1 from 3.60% to 5.614% per annum for the five-year period commencing June 30, 2026. While this is technically a modification of existing debt rather than a new issuance, the material change in interest rate terms on a $1 billion subordinated debt instrument is a significant financial obligation event that would affect investor assessment of the company's cost of capital and financial obligations. The announcement is structured as a debt-related disclosure under the trust indenture framework.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-29
The filing discloses a related-party transaction in which AXIA Energia and three subsidiaries assigned rights to use Optical Ground Wire (OPGW) cables and associated transmission infrastructure to Eletronet (a wholly-owned subsidiary) for telecommunications services. The transaction is valued at BRL 125,099,251.20 with a 20-year term and complies with ANEEL Normative Resolution No. 1,044/2022. This is a material operational/strategic arrangement involving infrastructure sharing and asset monetization that would affect a reasonable investor's assessment of the company's capital deployment and subsidiary operations.
View raw filing on EDGAR →
6-K
Governance Other
confidence 65%
filed 2026-06-29
EDENOR disclosed an upgrade of its issuer credit rating by S&P National Ratings from "raA+" to "raAA-", with outlook change from positive to stable. While credit rating changes are material to investors assessing financial risk and cost of capital, they do not fit neatly into the standard 8-K taxonomy. The disclosure is governance-adjacent (relating to the company's financial standing and market perception) rather than a discrete operational, financial, or legal event. Classified as governance_other because the domain is clearly governance/market-related but no specific named type applies.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-29
The 6-K furnishes a consolidated synthetic remote voting map for an Extraordinary General Meeting held on June 30, 2026, disclosing voting results on six resolutions. The core resolutions (Items 1–5) concern approval of a merger of Esfera Fidelidade S.A. into Banco Santander (Brasil), including ratification of the appraiser (PricewaterhouseCoopers), approval of the appraisal report, and approval of the merger protocol and transaction itself. These are material M&A-related shareholder votes with overwhelming approval (59+ million votes for on common shares). The disclosure is a post-vote reporting of shareholder approval results, fitting the shareholder_vote_results category under Item 5.07 equivalent.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 75%
filed 2026-06-29
Braskem discloses that Fitch Ratings and S&P Global Ratings have downgraded the Company's corporate credit rating to C and D respectively, in connection with a Precautionary Injunctive Relief proceeding. These are distressed-level credit ratings that signal severe financial stress and heightened delisting risk. While the filing does not explicitly mention delisting, the combination of emergency legal proceedings and catastrophic credit downgrades to near-default levels creates material delisting risk under NYSE continued listing standards.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-29
Item 7.01
Alliance announced a credit ratings upgrade from Moody's on its corporate family rating and senior secured debt facilities (B2 to B1), resulting in a 25 basis point reduction in borrowing costs on its term loan. While this is a positive financial development reflecting improved creditworthiness and enhanced financial flexibility, it does not fit neatly into the specific financial event categories (debt_issuance, covenant_breach, material_impairment, etc.). The upgrade is material to investors as it signals improved financial health and reduced future financing costs, but the event itself is a third-party credit rating action rather than a direct financial transaction or accounting event.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-29
Item 1.01
Emergent BioSolutions announced a contract modification valued at $52.7 million from the U.S. Department of Health and Human Services for supply of ACAM2000® vaccine under an existing 10-year government contract, representing a material operational and revenue milestone.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
This Item 5.07 filing discloses the results of Niagen Bioscience's 2026 Annual Meeting of Stockholders, including voting outcomes for three proposals: election of eight directors, ratification of Crowe LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents vote tallies (For, Against, Abstain, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-29
Item 8.01
Neurogene disclosed positive clinical trial data from its Phase 1/2 trial of NGN-401 gene therapy for Rett syndrome, including 47 developmental milestones gained across 10 participants with durable effects through 30 months and no treatment-related serious adverse events.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-29
EX-99.1
This is a company announcement of positive Phase 3 clinical trial results for epcoritamab (EPCORE DLBCL-4), demonstrating statistically significant improvement in progression-free survival. While the announcement discloses clinical development progress rather than financial results, regulatory approval, or a discrete corporate event, the positive Phase 3 data for a key pipeline asset in a major indication (relapsed/refractory DLBCL) represents material operational/strategic progress that would affect a reasonable investor's assessment of the company's pipeline value and commercial prospects. This is classified as operational_other because it is clearly an operational/strategic milestone (clinical trial success) that does not fit the earnings_release category (which is for financial results) or other specific event types.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
Dr. Joe Xiao was appointed to the Board of Directors on June 23, 2026, and simultaneously appointed to three key committees (Audit, Compensation, and Nominating and Corporate Governance). The disclosure centers on the appointment action itself, not on compensation arrangements or departures. Board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-29
Item 7.01
Creative Realities announced commencement of a public underwritten offering of common stock and pre-funded warrants, with an underwriter option for an additional 12.5% of shares. Proceeds will be used for working capital, debt paydown, and potential acquisitions under an effective Form S-3 shelf registration.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-29
EX-99.1
Bullish announced receipt of regulatory approval from the Gibraltar Financial Services Commission (GFSC) to offer trading in tokenized securities, positioning the company among the first regulated venues to do so. This is a material operational and strategic milestone that advances Bullish's broader strategy to build end-to-end infrastructure for tokenized securities, particularly in conjunction with its pending acquisition of Equiniti. The approval enables a new business line and regulatory capability that would affect investor assessment of the company's growth prospects and competitive positioning.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
NRC Health held its Annual Meeting of Stockholders on June 23, 2026, with shareholders voting on six proposals: election of seven directors, ratification of KPMG LLP as auditor, an advisory vote on named executive officer compensation, and three amendments to the certificate of incorporation. The detailed voting results for each proposal are disclosed.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Item 5.03
Stockholders approved and the board adopted amendments to NRC Health's certificate of incorporation and bylaws that materially alter the Company's governance structure, including removal of supermajority voting requirements, elimination of restrictions on director removal without cause, and lowering the threshold for stockholder action by written consent from unanimous to a simple majority.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-29
Item 4.01
The Company dismissed BCRG as its independent registered public accounting firm and appointed Simon & Edward LLP as the new auditor, effective June 26, 2026, following S&E's acquisition of BCRG's attest business. This is a classic auditor change disclosed under Item 4.01, with no adverse opinions, disagreements, or reportable events noted, indicating a routine transition driven by the acquisition rather than accounting or audit concerns.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
This Item 5.07 disclosure reports the results of the Company's Annual Meeting of Stockholders held on June 24, 2026, including voting outcomes on three proposals: election of five directors, advisory approval of named executive officer compensation, and ratification of PwC as independent auditor. The filing presents vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, confirming all three passed with substantial majorities. This is a textbook shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-29
Item 5.03
Barrel Energy Inc. filed a Corrective Amendment to its Certificate of Designation for Series A Preferred Stock on June 22, 2026, clarifying a 1:1,000 conversion ratio for 5 million preferred shares, representing 5 billion shares of common stock upon conversion. This amendment materially modifies shareholder rights and represents significant potential dilution to existing shareholders' equity and voting power.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-29
Item 3.02
Nexscient issued 816,000 restricted shares of common stock to two executive officers (President & CEO Fred Tannous and COO Tarek Shoufani) in settlement of $204,000 in accrued wages, relying on Section 4(a)(2) exemption from Securities Act registration. This is a classic unregistered equity issuance under Item 3.02, diluting existing shareholders. The transaction is material because it represents a significant equity grant to related parties and signals cash preservation concerns ahead of a planned uplisting.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-29
Item 7.01
The disclosure reports receipt of approximately $57 million in cash from Eli Lilly's acquisition of Ajax Therapeutics, a company co-founded by Schrödinger, plus eligibility for additional milestone-based payments. This is a financial event involving a material cash inflow and contingent consideration, but does not fit the specific M&A categories (which typically apply when the registrant itself is acquired or makes an acquisition) since Schrödinger is receiving proceeds from a third-party acquisition of an affiliate. The event is material to investors as it represents a significant capital receipt and future contingent cash flows.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-29
The filing discloses a registered direct offering of 11,038,767 shares of Class A common stock at $0.165 per share, generating approximately $1.8 million in gross proceeds. This is a material dilutive equity issuance under Item 1.01. While Item 5.02 also reports Alan Gaines' board resignation, the primary substantive event disclosed is the equity offering, which materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-29
EX-99.1
VivoPower announces selection of a preferred long-term tenant for its Mo i Rana AI data center in Norway, with further arrangements under negotiation across the company's wider pipeline. This is a material operational and strategic business development—the selection of a major tenant for a core asset and potential expansion of the relationship across multiple jurisdictions—but does not fit a discrete event category (not M&A, not a financing event, not a contract disclosure with specific terms). The announcement is conditional on execution of legal documentation and defers material commercial terms to a future announcement, making it a strategic milestone rather than a completed transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-29
Item 1.01
U.S. GoldMining entered into a securities purchase agreement to issue 522,876 shares of common stock at $7.65 per share in a registered direct offering, generating approximately $4.0 million in gross proceeds. This is a registered equity issuance that dilutes existing shareholders and represents a material capital-raising event for the company, with proceeds designated for working capital and general corporate purposes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-29
Item 3.02 discloses unregistered sales of common stock and warrant exercises during Q2 2026 under Section 4(a)(2) exemption, totaling approximately $7.36 million in gross proceeds. Item 7.01 provides detailed capital activity breakdown including multiple equity issuances at varying prices and warrant exercises. This represents a material dilutive equity issuance that would affect shareholder ownership and is a key indicator of capital-raising activity at a small-cap company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-29
The 8-K discloses financial results for fiscal year ended March 31, 2026, with net income of $1,305,722 ($0.64 per diluted share, down 24% YoY) and operating revenues of $6,561,324 (down 8% YoY). Item 2.02 explicitly states the registrant "issued a news release to announce its financial results," and the attached Exhibit 99.1 is a press release reporting annual earnings with detailed operational and reserve metrics. This is a standard earnings release disclosure.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-29
The filing discloses under Item 4.01 the dismissal of WithumSmith+Brown, PC as the independent registered public accounting firm effective June 26, 2026, and the concurrent engagement of Grant Thornton LLP as the new auditor. The filing explicitly states no disagreements or reportable events occurred, and the prior audit report contained no adverse opinions or qualifications, indicating a routine auditor transition rather than one driven by accounting disputes.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-29
Atlas Lithium disclosed receipt of an expansion permit from the permitting commission of Minas Gerais, Brazil on June 26, 2026, authorizing assembly and operation of its lithium processing plant and sale of lithium concentrate. This is a material operational and regulatory milestone that enables advancement of the Company's Neves Project as outlined in its Definitive Feasibility Study, but does not fit the specific categories of M&A activity, debt issuance, workforce reduction, or other named event types.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-29
EX-99.1
This press release announces a material strategic shift in the Company's drilling and development approach, moving from a single-bench focus (Lower Caney) to a multi-bench strategy targeting the False Caney, Upper Caney, T-zone, and Sycamore formations. The disclosure includes a revised 2026 forecast with production guidance of 4,700–5,200 boepd (17–30% increase), revenue of $78–84 million (37–48% increase), and Adjusted EBITDA of $56–62 million (33–47% increase). While the document contains forward-looking statements and operational updates on well drilling, the core event is a strategic business decision to expand the Company's development program and target new formations, which would materially affect a reasonable investor's assessment of the Company's growth prospects and reserve potential.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-29
Nova Minerals disclosed metallurgical test-work results from its Korbel gold deposit showing high-grade gold concentrate (up to 26.7 g/t Au) with >95% recovery using coarse particle flotation. The press release emphasizes this represents "a major breakthrough" with "potential to be a game changer for the project" by reducing capital and operating costs while improving gold recovery. This is a material operational/technical milestone in the company's feasibility study for the Estelle Gold Project, affecting investor assessment of project economics and development timeline.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-29
EX-99.1
Uxin announced the closing of a US$15 million investment involving the issuance of Class A ordinary shares at US$0.00953 per share to parties designated by NIO Capital under previously announced share subscription agreements. This is a partial closing of a larger US$50 million committed investment involving the issuance of 5,246,589,717 Class A ordinary shares. The transaction represents a dilutive equity issuance that would materially affect existing shareholders' ownership percentages and is therefore material to investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-29
Item 8.01
Tonix announced the first patient enrollment in HORIZON, a Phase 2 clinical trial evaluating TNX-102 SL for major depressive disorder. This represents a material operational and clinical development milestone for the company's pipeline expansion into a new indication, with approximately 360 patients expected to enroll in what is described as a potentially pivotal trial.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-29
EX-99.1
PowerBank has executed a Joint Development Agreement (JDA) with Nodiac to develop modular data centers at PowerBank's existing renewable energy sites. This is a material strategic partnership that unlocks new revenue streams from existing assets and represents a significant operational and business development milestone. The agreement establishes a framework for co-locating containerized AI compute infrastructure with PowerBank's solar and BESS sites across North America, aligning with the company's recently announced AI Data Center Strategy. While not a discrete M&A transaction, debt issuance, or other specifically-named event type, this partnership agreement materially advances PowerBank's strategic positioning in the high-growth AI infrastructure market and creates new business opportunities from its existing asset base.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-29
SharonAI announced the closing of a US$1.6 billion strategic financing comprising (i) a private placement of approximately US$900 million in Class A Ordinary Common Stock and pre-funded warrants, and (ii) a US$700 million private placement of 4.75% Convertible Senior Notes due 2032. The equity component (6,719,896 shares plus 6,374,823 warrant shares) represents a material dilutive issuance to existing shareholders. While the filing also includes a debt component, the primary disclosed action is the closing of the equity private placement, which is a classic dilutive issuance event material to investors.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-29
EX-99.1
Almonty's inclusion in the Russell 1000® and Russell 3000® indexes is a significant operational and market-recognition milestone. The company explicitly states this signals "the scale we have reached as a Western-aligned producer" and expects to benefit from "steadier trading liquidity and a more durable base of long-term shareholders" through access to the $12.2 trillion in assets benchmarked to Russell indexes. While not a discrete transaction or governance event, index inclusion materially affects investor accessibility and liquidity, making it material to a reasonable investor's assessment of the company's market position and shareholder base.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-29
NextBoat Inc. announced completion of a $45 million superyacht brokerage transaction through its Autograph Yacht Group division, described as "the largest brokerage transaction in the Company's history." The filing emphasizes this as a strategic milestone demonstrating the company's expansion into the ultra-high-net-worth market segment and validates its growth strategy of attracting top broker talent. While this is a significant business achievement, it does not constitute a material acquisition, disposition, or change of control (ruling out ma_activity), nor does it fit other specific event categories. The transaction is material to investors as it signals operational capability and revenue potential in a higher-margin market segment.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-06-29
The filing discloses a press release announcing operational and strategic updates: ETH holdings reaching 5.70 million tokens ($9.8 billion in total crypto and cash holdings), addition to the Russell 1000 index, completion of a $273.8 million Series A Preferred Stock offering, and launch of MAVAN staking infrastructure. While the offering completion could be classified as debt_issuance, the press release centers on operational achievements and strategic positioning rather than the financing event itself. The Russell 1000 inclusion and staking operations represent material operational developments affecting investor perception of the company's scale and market position.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Ocean Power Technologies amended and restated its Section 382 Tax Benefits Preservation Plan on June 29, 2026, extending the expiration date from June 29, 2026 to June 29, 2029. This is a governance matter involving modification of shareholder rights and anti-takeover protections. While the plan protects valuable NOL tax attributes (a financial benefit), the core disclosed action is a governance/structural change to the rights preservation mechanism itself, making governance_other the most appropriate classification. The materiality is high given the company's reliance on NOLs and the plan's role in deterring ownership changes that could limit tax benefits.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-29
The filing's primary content is Item 5.07, which discloses the results of the Annual Meeting of Stockholders held on June 26, 2026. The filing presents detailed voting results on five matters: election of nine directors, amendment to the 2022 Equity Incentive Plan, advisory vote on named executive officer compensation, and ratification of Deloitte & Touche as independent auditors. While Item 8.01 also discloses a 5% stock dividend declaration, the substantive focus and Item designation center on shareholder vote results, which is material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-06-29
Item 4.01 discloses the dismissal of BCRG as the Company's independent registered public accounting firm and simultaneous appointment of Simon & Edward LLP as the new auditor, effective June 23, 2026. The filing explicitly states the Audit Committee "simultaneously dismissed BCRG" and "approved the appointment of S&E," which is a clear auditor change. The materiality is heightened by the fact that BCRG's prior audit reports contained an explanatory paragraph indicating substantial doubt about the Company's ability to continue as a going concern.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-29
The filing discloses the Board's authorization and declaration of monthly dividend payments on Series A Preferred Stock ($4.791 per share) and Series 1 Preferred Stock ($4.583 per share), payable on or about July 13, 2026. This is a clear dividend distribution event under Item 8.01, material to investors as it affects shareholder returns and the company's capital allocation.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-29
The 6-K discloses the results of Robot Consulting Co., Ltd.'s Annual General Meeting of Shareholders held on June 26, 2026, with detailed voting tallies for all four proposals (approval of financial statements, election of statutory auditor, capital reduction and surplus disposition, and articles amendment). This is a classic shareholder_vote_results disclosure. The materiality is high because the proposals include capital reduction and articles amendment, which are structural changes affecting shareholders' interests.
View raw filing on EDGAR →